Skip to content

Ketamine: all studies

Page 110 of 448: studies 1,091 to 1,100 of 4,475, newest first. Back to the ketamine overview

Research

Accidental coadministration of medetomidine, vatinoxan and ketamine in a cat.

Veterinary anaesthesia and analgesia 2025 Maria Koura, Eleni Koliou, Stavroula Kourmpeti et al. 1 citation

An 8-month-old, Domestic Shorthair male cat was presented for elective orchiectomy. Preanaesthetic clinical examination was unremarkable. The anaesthetic plan included intramuscular medetomidine (30 μg kg-1) and tramadol (2 mg kg-1) for premedication followed by intramuscular ketamine (8 mg kg-1) for induction of general anaesthesia. The premedication mixture, presumed to be medetomidine and...

Cocaine and ketamine-induced paraspinal muscle compartment syndrome.

Turkish Journal of Emergency Medicine 2025 Thomas Saliba, Simone Giglioli, Sanjiva Pather et al. 1 citation

Lumbar paraspinal compartment syndrome is a rare pathology, with only 40 reported cases resulting from an increase in pressure within the muscle compartment. Symptoms typically involve pain and sometimes muscular deficits. The typical patient is a man who has undergone strenuous exercise, with few cases linked to the use of recreational drugs, such as cocaine or ketamine. We report the case of...

Case Report: Successful management of psychogenic non-epileptic seizures with intranasal esketamine.

Frontiers in Psychiatry 2025 Muneeb Hashmi, Padmasini Mugunthan, Priyal Jain et al. 2 citations

Psychogenic non-epileptic seizures (PNES), or functional seizures (FS), are episodes that resemble epileptic seizures but may be psychological in origin. Unlike epileptic seizures, which are linked to abnormal electrical activity in the brain, functional seizures may be associated with psychological and/or physical distress, and do not show the same electrical patterns on an...

Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review.

Frontiers in Psychiatry 2025 Mary R. Shen, Dylan E Campbell, Anika Kopczynski et al. 10 citations

Opioid use disorder (OUD) continues to be a public health crisis in the United States, with mortality having doubled over the last twenty years, leading to significant economic cost, morbidity, and mortality. This has caused significant demand for novel therapeutics. Preliminary evidence demonstrates that ketamine may be helpful in treating OUD as well as serve as an adjunct during treatment of...

Effects of ketamine on fear memory extinction: a review of preclinical literature.

Frontiers in Neuroscience 2025 Martin Boese, Rina Y. Berman, Kennett D. Radford et al. 5 citations

Ketamine, a multimodal dissociative anesthetic, is widely used as a trauma analgesic in emergency situations. Ketamine is also used to treat psychiatric disorders due to its broad application potential, including treatment-resistant major depression. However, its impacts on the development of post-traumatic stress disorder (PTSD) and its potential as a treatment for PTSD are controversial. PTSD...

DOI: 10.3389/fnins.2025.1546460 (opens in new tab) Full text (opens in new tab) Fear memory Molecular mechanism Translational research PTSD Treatment +4

Comparison of Esketamine/Propofol and Sufentanil/Propofol on Intraoperative Hypoxemia During Bronchoscopy: A Randomized Trial.

Drug Design, Development and Therapy 2025 Xiao Huang, Xueyang Li, Yuan Sun et al. 5 citations

Propofol and sufentanil are the most commonly used anesthetics during bronchoscopy. Esketamine is an s-enantiomer of ketamine racemate and has both sedative and analgesic effects, it does not inhibit respiration and maintains hemodynamic stability. We aimed to compare the intraoperative hypoxemia risk of esketamine/propofol with sufentanil/propofol for patients in bronchoscopy. This study was...

DOI: 10.2147/DDDT.S490423 (opens in new tab) Full text (opens in new tab) Propofol Sufentanil Bronchoscopy/endoscopy/respiratory procedures Sedation/anesthesia/procedural sedation +2

Butorphanol-azaperone-medetomidine and ketamine-butorphanol-azaperone-medetomidine chemical immobilization in habituated subadult female giraffe (Giraffa camelopardalis).

Veterinary anaesthesia and analgesia 2025 Silke Pfitzer, Liesel L Laubscher, Jacobus P Raath et al.

To describe the effects of butorphanol-azaperone-medetomidine (BAM) and ketamine-butorphanol-azaperone-medetomidine (KBAM) used for the chemical immobilization of giraffes. Quasi-experimental trial. A group of 10 habituated subadult female giraffes. Five giraffe were immobilized with BAM (0.02 mL cm-1 estimated shoulder height) and five with KBAM (0.015 mL cm-1 estimated shoulder height BAM and...

DOI: 10.1016/j.vaa.2025.04.009 (opens in new tab) Full text (opens in new tab) Kbam Anesthesia-protocols Veterinary-sedation Giraffe-medicine +1

Treatment-Resistant Depression: A Comprehensive Insight of Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychedelic-Assisted Psychotherapy

Annals of Punjab Medical College December 31, 2024 Mohammad Ali, Urbah Viqar

Background: The phenomenon of treatment-resistant depression (TRD) remains a problem in the sphere of mental health treatment since the majority of patients do not experience positive effects while receiving traditional treatments. Newer therapies are ketamine infusion therapy for depression, transcranial magnetic stimulation, and psilocybin-assisted psychotherapy give new hope. Objective: To...

Determining influences of intraoperative s-ketamine on postoperative delirium and cognitive function: methodology is important.

Journal of cardiothoracic surgery December 31, 2024 Dan-Feng Wang, Fei Gao, Fu-Shan Xue

The letter to the editor was written in response to the recent article by Wang et al. "The influence of low-dose s-ketamine on postoperative delirium and cognitive function in older adults undergoing thoracic surgery", which is published in Journal of Cardiothoracic Surgery. 2024; 19(1):324. This article concludes that intravenous low-dose S-ketamine during thoracic surgery in older patients...

Ketamine and Esketamine in Treatment of Resistant Depression

Archiv Euromedica December 26, 2024 Jakub Prosowski, Szczepan Pośpiech, Michał Piotrowski et al.

Aims: This review aims to explore the efficacy, mechanisms, administration routes, and safety profiles of ketamine and esketamine in the treatment of treatment-resistant depression (TRD). Methods: A comprehensive review of recent studies on ketamine and esketamine’s therapeutic applications in TRD was conducted. Sources included randomized controlled trials, systematic reviews, and...